Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideREGNRegeneron Pharmaceuticals
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | REGN | TMO |
|---|
| Close | 927.89 | 697.00 |
| Market Cap | $93.4B | $258B |
| 1M | +22.37% | +3.25% |
| P/E (TTM) | 19.5 | 36.4 |
| Forward P/E | 13.4 | 24.6 |
| P/E 5-Yr Percentile | 56 | 78 |
| P/S | 5.4 | 5.4 |
| P/B | 2.7 | 4.7 |
| Dividend Yield | 0.45% | 0.29% |
| Latest Quarter Revenue | $5.1B | $12.1B |
| Revenue YoY | +36.3% | +9.1% |
| Gross Margin | — | — |
| Latest Quarter EPS | 18.45 | 4.64 |
| Avg Post-Earnings Move | ±1.4% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.66% | 1.82% |
| 90-Day Net Insider Buying | −$6.5M | −$40.3M |
REGN · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
